Position in LLY
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$529,974,231
-$226,618,828 QoQ
Shares Held
576,203
-18.2% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026KBC Group NV holds $2,118,683,406 across 10 Drug Manufacturers - General names. LLY ranks #1 (25.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
576,203 | $529,974,231 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
2,679,656 | $373,463,655 | |
| 3 | JNJ |
Johnson & Johnson
|
1,269,307 | $310,269,402 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
4,009,205 | $243,158,282 | |
| 5 | PFE |
Pfizer Inc
|
8,471,914 | $237,891,345 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,217,611 | $146,466,425 | |
| 7 | ABBV |
AbbVie Inc.
|
669,647 | $145,641,525 | |
| 8 | AMGN |
Amgen Inc
|
252,179 | $88,729,180 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $529,974,231 | 576,203 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $756,593,059 | 704,017 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $527,912,070 | 691,890 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $475,019,855 | 609,367 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $458,117,410 | 554,682 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $454,714,948 | 589,009 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $501,295,858 | 565,835 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $563,682,343 | 622,592 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $372,838,106 | 479,251 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $334,826,331 | 574,395 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $295,307,627 | 549,788 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $302,932,470 | 645,939 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $194,432,727 | 566,166 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $255,234,494 | 697,667 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $257,903,635 | 797,599 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $195,974,986 | 604,432 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $191,101,859 | 667,325 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $202,676,148 | 733,749 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $129,107,274 | 558,785 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $115,847,695 | 504,739 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $101,721,621 | 544,490 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $108,819,743 | 644,514 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $48,354,729 | 326,677 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $40,169,263 | 244,666 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $55,929,822 | 403,185 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||